Article

Alcon launches two new vitrectomy technologies

Alcon Laboratories has introduced two vitrectomy technologies designed to help surgeons deliver a higher level of precision and efficiency during retina surgery.

 

Fort Worth, TX-Alcon Laboratories has introduced two vitrectomy technologies designed to help surgeons deliver a higher level of precision and efficiency during retina surgery.

The two technologies were unveiled last week at the American Society of Retina Specialists annual meeting in San Diego.

More from this issue: AMA wants Sunshine Act database publication delayed

The Ultravit high-speed vitrectomy probe operates at an ultra-high-speed of 7,500 cpm, according to Alcon, and the increased speed helps reduce traction that can cause iatrogenic tears and postoperative complications.

The probe also features a dual-pneumatic drive that helps enable flow and shearing at high cut rates.

 

According to the company, the dual-pneumatic technology-in conjunction with Constellation duty cycle control-supports surgeons performing a wide range of maneuvers addressing several pathologies.

Alcon also introduced a new portfolio of 27+ series instruments and accessories that are designed to allow surgeons to reduce incision size and provide access to small tissue planes with a stiffness experience similar to 25+ instrumentation.

Both technologies are now available in the United States.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Related Videos
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.